Nonsteroidal anti-inflammatory drug use and alzheimer's disease: A case-control study in Rochester, Minnesota, 1980 through 1984

Mayo Clinic Proceedings

Volumn 73, Issue 10, 1998, Pages 951-955

  Mary Beard, C ^a   Waring, Stephen C ^a   O'Brien, Peter C ^b   Kurland, Leonard T ^b   Kokmen, Emre ^b  

^a Section of Clinical Epidemiology   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANACIN; ASCRIPTIN; BENOXAPROFEN; BUTALBITAL; DEXTROPROPOXYPHENE; FENOPROFEN CALCIUM; IBUPROFEN; INDOMETACIN; MAGNESIUM SALICYLATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORGESIC; PARACETAMOL; PERCODAN; PHENYLBUTAZONE; PIROXICAM; SALSALATE; SULINDAC; ZOMEPIRAC;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ONSET AGE; PRESCRIPTION;

EID: 0031686954     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.10.951     Document Type: Article

References (27)

1. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43:1609-1611
2. Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-232
3. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology ±995-45:51-55
4. Canadian Study of Health and Aging. The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology 1994:44:2073-2080
5. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48:626-632
6. McGeer PL, Walker DG, Akiyama H, Kawamata T, Guan AL, Parker CJ, et al. Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res 1991;544:315319
7. Kurland LT, Molgaard CA. The patient record in epidemiology. Sei Am 1981 Oct; 245:54-63
8. Kokmen E, Beard CM, O'Brien PC, Offord KP, Kurland LT. Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology 1993;43:1887-1892
9. Breitner JC, Magruder-Habib KM. Criteria for onset critically influence the estimation of familial risk in Alzheimer's disease. Genet Epidemiol 1989:6:663-669
10. Physicians' Desk Reference for Nonprescription Drugs. 6th ed. Oradell (NJ): Medical Economics; 1985. p 714
11. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol 1: The Analysis of Case-Control Studies. Lyon (France): International Agency for Research on Cancer; 1980
12. Sturmer T, Glynn RJ, Field TS, Taylor JO, Hennekens CH. Aspirin use and cognitive function in the elderly. Am J Epidemiol 1996:143:683691
13. Physicians' Desk Reference to Pharmaceutical Specialties and Biologicals. Oradell (NJ): Medical Economics; 1965. pp 779-780
14. Broe GA, Henderson AS, Creasey H, McCusker E, Körten AE, Jorm AF, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990:40:1698-1707
15. French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B. A case-control study of dementia of the Alzheimer type. Am J Epidemiol 1985;121:414-421
16. Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D, et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986;36:922931
17. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991;41:1393-1397
18. Wolf-Klein GP, Silverstone FA, Brod MS, Levy A, Foley CJ, Termotto V, et al. Are Alzheimer patients healthier? J Am Geriatr Soc 1988;36:219-224
19. Breteler MM, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al (EURODEM Risk Factors Research Group). Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(Suppl 2):S36-S42
20. Beard CM, Kokmen E, Kurland LT. Rheumatoid arthritis and susceptibility to Alzheimer's disease [letter]. Lancet 1991;337:1426
21. Rosenberg MJ, Layde PM, Ory HW, Strauss LT, Rooks JB, Rubin GL. Agreement between women's histories of oral contraceptive use and physician records. Int J Epidemiol 1983:12:84-87
22. Oliver MF, Boyd GS. Influence of reduction of serum lipids on prognosis of coronary heart-disease: a five-year study using oestrogen. Lancet 1961;2:499-505
23. Unlisted Drugs 1963;15:27
24. Micromedex Computerized Clinical Information System. Vol 89. Denver: Micromedex; 1974
25. Jorm AF, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al (EURODEM Risk Factors Research Group). Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(Suppl 2):S43-S47
26. Physicians'Desk Reference. 29th ed. Oradell (NJ): Medical Economics; 1975. p 1527
27. Beard CM, Kottke TE, Annegers JF, Ballard DJ. The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982. Mayo Clin Proc 1989;64:1471-1480